Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses have?
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses has 129 citations in the OpenAlex counts ScholarIQ stores.
When was Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses published?
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses has 2011 year in the ScholarIQ index.
What is the open-access status of Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses?
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses has closed oa status in the ScholarIQ index.
What is the DOI of Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses?
The DOI for Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses is on the source record.
What is the PMID of Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses?
The PMID for Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses is on the source record.
What is the OpenAlex record for Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses?
The OpenAlex for Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/<i>lpr</i> mice by inhibiting Th1 and Th17 cell responses is on the source record.